Shares of computer processor maker AMD (NASDAQ:AMD) fell 5.9% in the morning session after Goldman Sachs analyst Toshiya Hari ...

AMD’s AI advancements are overshadowed by Nvidia’s CUDA. Find out why AMD stock is overvalued, while NVDA continues to lead ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Advanced Micro Devices' diversified revenue streams provide a cushion against potential slowdowns in AI hardware CapEx. See ...

Nvidia launched its 50-series line-up of graphics cards. But when it comes to GPU, it's always a question of AMD vs. Nvidia.

At its CES exposition, AMD demonstrated its latest Instinct MI325X accelerator for AI and HPC workloads, which also happens ...

AMD's new Adrenalin AI for RDNA 4 graphics cards brings several local generative AI tools to next-gen Radeon GPUs, for ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at ...

Investing.com -- Shares of Absci Corporation (NASDAQ: ABSI) soared 50% following the announcement of a strategic ...

Dell’s embrace of AMD for corporate PCs — it already uses the chipmaker for consumer devices — is another blow for Intel Corp ...